Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit
cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at
opm.gov.
Quantifying, Explaining and Predicting Survival After Diagnosis of HIV-related Kaposi Sarcoma in East Africa
The following grant was awarded by, is supported by, is administered by or is in partnership with the Fogarty International Center at the U.S. National Institutes of Health (NIH).
Funding Fogarty Program
Emerging Global Leader
Project Information in NIH RePORTER
Quantifying, Explaining and Predicting Survival After Diagnosis of HIV-related Kaposi Sarcoma in East Africa
Principal Institution
Infectious Diseases Institute
Principal Investigator(s) (PI)
Byakwaga, Helen
Project Contact Information
Email:
hbyakwaga@gmail.com
Year(s) Awarded
2021-2026
Country
Uganda
NIH Partners
NCI
Project Description
In sub-Saharan Africa, Kaposi’s sarcoma (KS) is one of the most commonly reported cancers in the general population, and is associated with considerable morbidity and mortality in HIV-infected individuals. This project addresses the problem by supporting the career development of an emerging young scientist dedicated to understanding the impact of KS on mortality among the HIV-infected population, to identify potential biologic pathways that predict death after KS diagnosis, and to develop a prediction rule for mortality among HIV-infected individuals with KS in the region. This investment will increase the possibility of developing strategies to reduce the burden of KS among HIV-infected individuals in the era of effective anti-retroviral therapy.
Related World Regions / Countries
Related Global Health Research Topics